Muscle-Specific Mis-Splicing and Heart Disease Exemplified by RBM20
AbstractAlternative splicing is an essential post-transcriptional process to generate multiple functional RNAs or proteins from a single transcript. Progress in RNA biology has led to a better understanding of muscle-specific RNA splicing in heart disease. The recent discovery of the muscle-specific splicing factor RNA-binding motif 20 (RBM20) not only provided great insights into the general alternative splicing mechanism but also demonstrated molecular mechanism of how this splicing factor is associated with dilated cardiomyopathy. Here, we review our current knowledge of muscle-specific splicing factors and heart disease, with an emphasis on RBM20 and its targets, RBM20-dependent alternative splicing mechanism, RBM20 disease origin in induced Pluripotent Stem Cells (iPSCs), and RBM20 mutations in dilated cardiomyopathy. In the end, we will discuss the multifunctional role of RBM20 and manipulation of RBM20 as a potential therapeutic target for heart disease. View Full-Text
Share & Cite This Article
Rexiati, M.; Sun, M.; Guo, W. Muscle-Specific Mis-Splicing and Heart Disease Exemplified by RBM20. Genes 2018, 9, 18.
Rexiati M, Sun M, Guo W. Muscle-Specific Mis-Splicing and Heart Disease Exemplified by RBM20. Genes. 2018; 9(1):18.Chicago/Turabian Style
Rexiati, Maimaiti; Sun, Mingming; Guo, Wei. 2018. "Muscle-Specific Mis-Splicing and Heart Disease Exemplified by RBM20." Genes 9, no. 1: 18.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.